Influence of Vitamin D in advanced non-small cell lung cancer patients treated with nivolumab

J. Cusato, C. Genova, C. Tomasello, P. Carrega, S. Ottonello, G. Pietra, M.C. Mingari, I. Cossu, E. Rijavec, A. Leggieri, G. Di Perri, M.G. Dal Bello, S. Coco, S. Boccardo, G. Ferlazzo, F. Grossi, A. D’Avolio

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCancers
Volume11
Issue number1
DOIs
Publication statusPublished - 2019

Keywords

  • ELISA
  • Immunotherapy
  • Monoclonal antibody
  • NSCLC
  • Pharmacogenetics
  • Pharmacokinetics
  • 25 hydroxyvitamin D
  • nivolumab
  • vitamin D
  • aged
  • Article
  • clinical article
  • enzyme linked immunosorbent assay
  • female
  • gene frequency
  • genotype
  • heterozygosity
  • homozygosity
  • human
  • male
  • non small cell lung cancer
  • pharmacogenetics
  • real time polymerase chain reaction
  • single nucleotide polymorphism
  • tumor growth
  • vitamin blood level

Cite this